https://en.sputniknews.africa/20230816/first-case-of-covid-19-eg5-variant-in-south-africa-confirmed-by-health-dept-1061372728.html
First Case of Covid-19 EG.5 Variant in South Africa Confirmed by Health Dept
First Case of Covid-19 EG.5 Variant in South Africa Confirmed by Health Dept
Sputnik Africa
COVID-19 variant EG.5, also referred to as Eris, was first reported on February 17 and assigned as a variant under monitoring by the World Health Organization... 16.08.2023, Sputnik Africa
2023-08-16T18:10+0200
2023-08-16T18:10+0200
2023-08-16T18:10+0200
sub-saharan africa
world health organization (who)
south africa
southern africa
covid-19
health
healthcare
https://cdn1.img.sputniknews.africa/img/07e7/04/16/1058782480_0:160:3073:1888_1920x0_80_0_0_4d432f63529fccfa343b7e370433194b.jpg
The first case of COVID-19 variant EG.5, or Eris, has been confirmed by the National Department of Health in South Africa, local media reported.The case was confirmed in a sample in the province of Gauteng, the department confirmed, against the backdrop of an increase in COVID infections and hospitalizations in the US, Europe, and Asia.The WHO suggested that the Eris variant won't be alarming, despite the fact that it can cause an increase in infections.Eris has the same symptoms as other COVID-19 variants, such as fever, cough, shortness of breath, fatigue, muscle aches, sore throat, and headache.Andrea Garcia, the American Medical Association's vice president for science, medicine, and public health, told US media last month that EG.5 doesn’t seem to cause an infection worse than the prior Omicron subvariants and may be more susceptible to newer COVID-19 vaccines, including those expected to be rolled out by pharmaceutical companies in the coming months.South Africans have been urged by the Health Department to get vaccinated, according to the media.Data from the US Centers for Disease Control and Prevention (CDC) on August 5 showed that EG.5 is responsible for between 14-21% of new COVID-19 cases in the US. While that’s not a majority, it’s the largest among a slew of other Omicron subvariants, including the XBB.1.5 subvariant that dominated the US outbreak in the spring of 2023.
https://en.sputniknews.africa/20230816/us-begins-preparing-for-new-pandemic-by-searching-for-virus-mutations-russian-mod-1061368869.html
south africa
southern africa
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2023
Samantha Arias
https://cdn1.img.sputniknews.africa/img/07e7/0a/18/1063050346_115:0:834:719_100x100_80_0_0_1682778780537fd5aa8dd2536a012c1b.jpg
Samantha Arias
https://cdn1.img.sputniknews.africa/img/07e7/0a/18/1063050346_115:0:834:719_100x100_80_0_0_1682778780537fd5aa8dd2536a012c1b.jpg
News
en_EN
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Samantha Arias
https://cdn1.img.sputniknews.africa/img/07e7/0a/18/1063050346_115:0:834:719_100x100_80_0_0_1682778780537fd5aa8dd2536a012c1b.jpg
world health organization (who), south africa, southern africa, covid-19, health, healthcare
world health organization (who), south africa, southern africa, covid-19, health, healthcare
First Case of Covid-19 EG.5 Variant in South Africa Confirmed by Health Dept
COVID-19 variant EG.5, also referred to as Eris, was first reported on February 17 and assigned as a variant under monitoring by the World Health Organization (WHO) on July 19. Based on the risk evaluation, EG.5 and its sub-lineages were designated as a variant of interest by the UN body.
The first case of COVID-19 variant EG.5, or Eris, has been confirmed by the National Department of Health in South Africa, local media reported.
The case was confirmed in a sample in the province of Gauteng, the department confirmed, against the backdrop of an increase in COVID infections and hospitalizations in the US, Europe, and Asia.
The
WHO suggested that the Eris variant won't be alarming, despite the fact that it can cause an increase in infections.
Eris has the same symptoms as other COVID-19 variants, such as fever, cough, shortness of breath, fatigue, muscle aches, sore throat, and headache.
Andrea Garcia, the American Medical Association's vice president for science, medicine, and public health, told US media last month that
EG.5 doesn’t seem to cause an infection worse than the prior Omicron subvariants and may be more susceptible to newer COVID-19 vaccines, including those expected to be rolled out by
pharmaceutical companies in the coming months.
South Africans have been urged by the Health Department to get vaccinated, according to the media.
Data from the US Centers for Disease Control and Prevention (CDC)
on August 5 showed that EG.5 is responsible for between 14-21% of new COVID-19 cases in the US. While that’s not a majority, it’s the largest among a slew of other Omicron subvariants, including the XBB.1.5 subvariant that dominated the US outbreak in the spring of 2023.
